These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28538086)

  • 1. Sphingosine-1-Phosphate Receptor-1 Agonist Sew2871 Causes Severe Cardiac Side Effects and Does Not Improve Microvascular Barrier Breakdown in Sepsis.
    Flemming S; Burkard N; Meir M; Schick MA; Germer CT; Schlegel N
    Shock; 2018 Jan; 49(1):71-81. PubMed ID: 28538086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic targeting of sphingosine-1-phosphate receptor 1 improves the renal microcirculation during sepsis in the mouse.
    Wang Z; Sims CR; Patil NK; Gokden N; Mayeux PR
    J Pharmacol Exp Ther; 2015 Jan; 352(1):61-6. PubMed ID: 25355645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingosin-1-phosphate Receptor 1: a Potential Target to Inhibit Neuroinflammation and Restore the Sphingosin-1-phosphate Metabolism.
    Kolahdooz Z; Nasoohi S; Asle-Rousta M; Ahmadiani A; Dargahi L
    Can J Neurol Sci; 2015 May; 42(3):195-202. PubMed ID: 25860537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S1P(1)-selective agonist, SEW2871, ameliorates ischemic acute renal failure.
    Lien YH; Yong KC; Cho C; Igarashi S; Lai LW
    Kidney Int; 2006 May; 69(9):1601-8. PubMed ID: 16572108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
    Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
    Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine-1-phosphate prevents tumor necrosis factor-{alpha}-mediated monocyte adhesion to aortic endothelium in mice.
    Bolick DT; Srinivasan S; Kim KW; Hatley ME; Clemens JJ; Whetzel A; Ferger N; Macdonald TL; Davis MD; Tsao PS; Lynch KR; Hedrick CC
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):976-81. PubMed ID: 15761190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosine-1-Phosphate Receptor 1 Activation Enhances Leptomeningeal Collateral Development and Improves Outcome after Stroke in Mice.
    Iwasawa E; Ishibashi S; Suzuki M; Li F; Ichijo M; Miki K; Yokota T
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1237-1251. PubMed ID: 29337049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sphingosine-1-phosphate receptor 1 agonist SEW2871 prolongs heterotopic heart allograft survival in mice.
    Ni Q; Yuan B; Liu T; Lan F; Luo X; Lu X; Huang P; Dai L; Jin X; Yin H
    Int Immunopharmacol; 2015 May; 26(1):37-42. PubMed ID: 25776899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sinusoidal protection by sphingosine-1-phosphate receptor 1 agonist in liver ischemia-reperfusion injury.
    Ito T; Kuriyama N; Kato H; Matsuda A; Mizuno S; Usui M; Sakurai H; Isaji S
    J Surg Res; 2018 Feb; 222():139-152. PubMed ID: 29273365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sphingosine 1-phosphate receptor, S1PR₁, plays a prominent but not exclusive role in enhancing the excitability of sensory neurons.
    Chi XX; Nicol GD
    J Neurophysiol; 2010 Nov; 104(5):2741-8. PubMed ID: 20844107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase 4 inhibition dose dependently stabilizes microvascular barrier functions and microcirculation in a rodent model of polymicrobial sepsis.
    Flemming S; Schlegel N; Wunder C; Meir M; Baar W; Wollborn J; Roewer N; Germer CT; Schick MA
    Shock; 2014 Jun; 41(6):537-45. PubMed ID: 24569506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate.
    Jo E; Sanna MG; Gonzalez-Cabrera PJ; Thangada S; Tigyi G; Osborne DA; Hla T; Parrill AL; Rosen H
    Chem Biol; 2005 Jun; 12(6):703-15. PubMed ID: 15975516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping pathways downstream of sphingosine 1-phosphate subtype 1 by differential chemical perturbation and proteomics.
    Gonzalez-Cabrera PJ; Hla T; Rosen H
    J Biol Chem; 2007 Mar; 282(10):7254-64. PubMed ID: 17218309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine 1-Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex-Induced Vascular Injury.
    Burg N; Swendeman S; Worgall S; Hla T; Salmon JE
    Arthritis Rheumatol; 2018 Nov; 70(11):1879-1889. PubMed ID: 29781582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alteration of sphingolipid metabolism as a putative mechanism underlying LPS-induced BBB disruption.
    Vutukuri R; Brunkhorst R; Kestner RI; Hansen L; Bouzas NF; Pfeilschifter J; Devraj K; Pfeilschifter W
    J Neurochem; 2018 Jan; 144(2):172-185. PubMed ID: 29023711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off the shelf but not mass produced.
    Karliner JS
    Chem Biol; 2005 Jun; 12(6):614-5. PubMed ID: 15975506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevation of serum sphingosine-1-phosphate attenuates impaired cardiac function in experimental sepsis.
    Coldewey SM; Benetti E; Collino M; Pfeilschifter J; Sponholz C; Bauer M; Huwiler A; Thiemermann C
    Sci Rep; 2016 Jun; 6():27594. PubMed ID: 27277195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine-1-phosphate receptors mediate neuromodulatory functions in the CNS.
    Sim-Selley LJ; Goforth PB; Mba MU; Macdonald TL; Lynch KR; Milstien S; Spiegel S; Satin LS; Welch SP; Selley DE
    J Neurochem; 2009 Aug; 110(4):1191-202. PubMed ID: 19493165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulating sphingosine 1-phosphate signaling with DOP or FTY720 alleviates vascular and immune defects in mouse sepsis.
    Hemdan NY; Weigel C; Reimann CM; Gräler MH
    Eur J Immunol; 2016 Dec; 46(12):2767-2777. PubMed ID: 27683081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S1P1 receptor modulation preserves vascular function in mesenteric and coronary arteries after CPB in the rat independent of depletion of lymphocytes.
    Samarska IV; Bouma HR; Buikema H; Mungroop HE; Houwertjes MC; Absalom AR; Epema AH; Henning RH
    PLoS One; 2014; 9(5):e97196. PubMed ID: 24819611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.